|Table 1: Evolution of prevalence and means of cardiometabolic risk factors during the four-year follow-up period ().|
|Values are expressed as means ± SD or percentage. |
BP: blood pressure, FG: fasting glycemia, HDL-C: high density lipoprotein cholesterol, TC: total cholesterol, WC: waist circumference, TG: triglycerides, MetS: metabolic syndrome, FRS: framingham risk score.
: for -test or test.
b33 subjects (23 women and 10 men) under medical treatment for high blood pressure are excluded.
cIncludes 33 subjects (23 women and 10 men) under medical treatment for high blood pressure.
d4 subjects (1 woman and 3 men) under medical treatment for diabetes are excluded.
eIncludes 4 subjects under treatment for diabetes.